Mitomycin C in the treatment of a Schneiderian (inverted) papilloma of the lacrimal sac
Authors:
- 23 July 2009
- journal article
- case report
- Published by Springer Nature in International Ophthalmology
- Vol. 30 (3) , 303-305
Abstract
Schneiderian papillomas are benign tumours, with an aggressive nature. A case with a recurrent Schneiderian papilloma of the nasolacrimal sac, who underwent an external dacryocystorhinostomy (DCR) with irrigation of the nasolacrimal system with 0.02% mitomycin C (MMC), is presented at 18 months follow-up. External DCR using MMC, as an adjuvant therapy, is a novel approach to the treatment of Schneiderian papilloma of the nasolacrimal tract. It allows preservation of function, compared with the conventional treatment of dacryocystectomy.Keywords
This publication has 6 references indexed in Scilit:
- Management of lacrimal sac tumoursEye, 2003
- Treatment outcomes of primary and recurrent inverted papilloma: an analysis of 96 casesThe Journal of Laryngology & Otology, 2002
- Topical and intralesional interferon therapy for recurrent lacrimal papillomaEye, 2002
- The Effect of Intravesical Mitomycin C on the Recurrence of Superficial (Ta–T1) Bladder Cancer. A Hungarian Multicenter StudyInternational Urology and Nephrology, 1999
- The clinical behavior of inverting papilloma of the nose and paranasal sinuses: Report of 112 cases and review of the literatureThe Laryngoscope, 1990
- Papillomas of lacrimal drainage system: a clinicopathologic study.1984